Van Hoose Kyri K.
SEC insider (Form 3/4/5 filer). CIK 0001860885. SVP, CFO at Dermata Therapeutics, Inc. (DRMA). 6 reported Form 4/5 transactions since Sep 2024; latest on Aug 16, 2026. Located in SAN DIEGO, CA.
Companies Van Hoose Kyri K. has filed insider reports for
- Dermata Therapeutics, Inc. (DRMA): Officer, SVP, CFO
Van Hoose Kyri K.
CIK: 0001860885
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Dermata Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Aug 16, 2026DRMA
Dermata Therapeutics, Inc.
AwardDirect102K shares- - Jan 2, 2026DRMA
Dermata Therapeutics, Inc.
AwardDirectStock Option (right to buy)
18K shares- - Dec 23, 2025DRMA
Dermata Therapeutics, Inc.
AwardDirect122.5K shares- - Dec 23, 2025DRMA
Dermata Therapeutics, Inc.
DispositionDirectWarrant (Right to Buy)
7.9K shares- - Jan 21, 2025DRMA
Dermata Therapeutics, Inc.
AwardDirect78.7K shares- - Jan 13, 2025DRMA
Dermata Therapeutics, Inc.
AwardDirectStock Option (right to buy)
20K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 16, 2026 | DRMA Dermata Therapeutics, Inc. | Award | 102,040 | - | $0 | Direct |
| Jan 2, 2026 | DRMA Dermata Therapeutics, Inc. | Award Stock Option (right to buy) | 18,000 | - | - | Direct |
| Dec 23, 2025 | DRMA Dermata Therapeutics, Inc. | Award | 122,549 | - | - | Direct |
| Dec 23, 2025 | DRMA Dermata Therapeutics, Inc. | Disposition Warrant (Right to Buy) | 7,874 | - | - | Direct |
| Jan 21, 2025 | DRMA Dermata Therapeutics, Inc. | Award | 78,741 | - | $0 | Direct |
| Jan 13, 2025 | DRMA Dermata Therapeutics, Inc. | Award Stock Option (right to buy) | 20,000 | - | - | Direct |
1-6 of 6 transactions